ULBI vs. STEM, GWH, NVX, ELVA, CBAT, FLUX, DFLI, SES, COMM, and CANG
Should you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include Stem (STEM), ESS Tech (GWH), NOVONIX (NVX), Electrovaya (ELVA), CBAK Energy Technology (CBAT), Flux Power (FLUX), Dragonfly Energy (DFLI), SES AI (SES), CommScope (COMM), and Cango (CANG). These companies are all part of the "computer and technology" sector.
Stem (NYSE:STEM) and Ultralife (NASDAQ:ULBI) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.
Ultralife has lower revenue, but higher earnings than Stem. Stem is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks.
Ultralife has a net margin of 6.19% compared to Ultralife's net margin of -40.03%. Stem's return on equity of 10.31% beat Ultralife's return on equity.
Ultralife received 233 more outperform votes than Stem when rated by MarketBeat users. Likewise, 71.51% of users gave Ultralife an outperform vote while only 41.18% of users gave Stem an outperform vote.
Stem currently has a consensus price target of $4.77, indicating a potential upside of 275.83%. Ultralife has a consensus price target of $13.00, indicating a potential upside of 15.56%. Given Ultralife's higher probable upside, equities analysts plainly believe Stem is more favorable than Ultralife.
61.6% of Stem shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 10.2% of Stem shares are held by company insiders. Comparatively, 42.7% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Stem has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.
In the previous week, Stem and Stem both had 1 articles in the media. Stem's average media sentiment score of 0.85 beat Ultralife's score of 0.18 indicating that Ultralife is being referred to more favorably in the news media.
Summary
Ultralife beats Stem on 12 of the 17 factors compared between the two stocks.
Get Ultralife News Delivered to You Automatically
Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ultralife Competitors List
Related Companies and Tools
